CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Total Lendway Stockholders' Equity	Common Stock	Additional Paid-In Capital	Other Comprehensive Loss	Accumulated Deficit	Noncontrolling Interest	Total
Beginning balance, shares at Dec. 31, 2022		1,797,000
Beginning balance, amount at Dec. 31, 2022	$ 13,401,000	$ 18,000	$ 16,458,000		$ (3,075,000)		$ 13,401,000
Repurchase of common stock, Shares		(84,000)
Repurchase of common stock, amount	(482,000)	$ (1,000)	(481,000)				(482,000)
Issuance of common stock, net shares		24,000
Issuance of common stock, net amount	155,000		155,000				155,000
Issuance of common stock upon vesting of restricted stock units, shares		6,000
Value of stock-based compensation	44,000		44,000				44,000
Net income (loss)	2,414,000				2,414,000		2,414,000
Ending balance, shares at Dec. 31, 2023		1,743,000
Ending balance, amount at Dec. 31, 2023	15,532,000	$ 17,000	16,176,000		(661,000)		$ 15,532,000
Issuance of common stock upon vesting of restricted stock units, shares		27,000					27,000
Issuance of noncontrolling interests in acquisition						$ 2,990,000	$ 2,990,000
Value of stock-based compensation	60,000		60,000				60,000
Net income (loss)	(5,743,000)				(5,743,000)	(934,000)	(6,677,000)
Other comprehensive loss	(9,000)			$ (9,000)		(2,000)	(11,000)
Ending balance, shares at Dec. 31, 2024		1,770,000
Ending balance, amount at Dec. 31, 2024	$ 9,840,000	$ 17,000	$ 16,236,000	$ (9,000)	$ (6,404,000)	$ 2,054,000	$ 11,894,000